HR 88
Medical Innovation Acceleration Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 13, 2026, 4:11 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Medical Innovation Acceleration Act of 2025 aims to speed up the development and availability of new medical technologies by exempting certain diagnostic devices from the usual regulatory oversight of the Food and Drug Administration (FDA). Specifically, the bill defines ‘non-invasive diagnostic devices’ as those that don’t penetrate the body, cause minimal physical changes, and don’t use radiation. This change is intended to reduce the burden of FDA regulation on these devices, potentially leading to faster innovation in healthcare.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.